A cost –utility analysis of decompressive hemicraniectomy versus medical treatment in the management of space‐occupying brain oedema post middle cerebral artery infarction

DiscussionThis is above the National Institute for Health and Care Excellence (NICE) ‘cost‐effective’ threshold of £20 000–£30 000 per QALY, but lower mortality rates associated with the surgical alternative raises ethical considerations for healthcare providers in the UK.

Source: European Journal of Neurology - November 15, 2018 Category: Neurology Authors: A. Bhattacharyya, A. Tahir, A. Chandrashekar, S. Vasisht, L. Stinson, J. Omatseye Tags: Original Article Source Type: research